How ALICE Applies in Pharmaceuticals & Life Sciences
FDA 21 CFR Part 11 requires validated electronic records and audit trails for every system touching clinical trial data, manufacturing execution, and regulatory submissions. ALICE enforces data integrity constraints at the commit level. Validation documentation is generated continuously throughout the build — not assembled under deadline pressure during an FDA inspection.
Pharmaceutical engagements are among the highest-stakes software environments. ALICE makes it impossible to ship a system that would fail an FDA audit because it enforces validation requirements before code leaves the development environment.
This is the single most important reason our teams deliver compliance-native systems. ALICE makes it mechanically impossible to ship non-compliant code. It's not a QA phase — it's infrastructure-level enforcement at every commit.
Healthcare Compliance Frameworks
ALICE enforces these frameworks at the infrastructure level across every healthcare engagement. Compliance documentation is generated throughout the build — not assembled before the audit.
Deployed as Part of Every Algorithm Engagement
ALICE is not a vendor integration that Algorithm engineers configure for clients. It is embedded infrastructure that ships as part of every relevant engagement. Healthcare organizations that engage Algorithm do not receive a system and a separate compliance tool. They receive a system where ALICE is already running — from the first deploy.
Domain: QA & Compliance Engine
Sector: Healthcare
Status: live